Brussels, Belgium

Olivier Lorthioir

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ucb Pharma, S.a.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Olivier Lorthioir. Retrieved from https://idiyas.com/inventor/olivier-lorthioir

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Olivier Lorthioir: Innovator in Pharmaceutical Chemistry

Introduction

Olivier Lorthioir is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on piperidinyl derivatives. His expertise and dedication to research have led to the development of valuable pharmaceutical compositions.

Latest Patents

Olivier Lorthioir holds a patent for 2-oxo-piperidinyl derivatives. This invention relates to the preparation of these derivatives, the pharmaceutical compositions that contain them, and their applications as pharmaceuticals. His work in this area demonstrates his commitment to advancing medical science and improving therapeutic options.

Career Highlights

Lorthioir is currently associated with UCB Pharma S.A., a leading global biopharmaceutical company. His role at UCB Pharma allows him to collaborate with other experts in the field and contribute to the development of innovative treatments. His career reflects a strong focus on research and development in pharmaceuticals.

Collaborations

Olivier has worked alongside talented colleagues such as Ali Ates and Florian Montel. These collaborations have fostered a productive environment for innovation and have led to advancements in their shared field of expertise.

Conclusion

Olivier Lorthioir is a distinguished inventor whose work on 2-oxo-piperidinyl derivatives has the potential to impact the pharmaceutical industry significantly. His contributions, along with his collaborations, highlight the importance of innovation in developing new medical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…